<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MedPage Today Dermatology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'MedPage Today Dermatology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=MedPage+Today+Dermatology&t=MedPage+Today+Dermatology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 13:12:35 +0100</lastBuildDate>
        <item>
            <title>New Psoriasis Guidelines Expand Treatment Options (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5638560&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F30892</link>
            <description>(MedPage Today) -- Newer biologic agents for treating moderate-to-severe plaque psoriasis can be considered for first-line use in some cases, according to new treatment guidelines from the National Psoriasis Foundation. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638560</comments>
            <pubDate>Sun, 29 Jan 2012 16:13:02 +0100</pubDate>
            <guid isPermaLink="false">5638560</guid>        </item>
        <item>
            <title>Lab Notes: Steak and Surgery May Not Mix</title>
            <link>http://www.medworm.com/index.php?rid=5638561&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FLabNotes%2FLabNotes%2F30887</link>
            <description>(MedPage Today) -- Tops in this week's edition, research in mice suggests that taking protein out of patients' diets a few days before surgery could reduce the risk of complications. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638561</comments>
            <pubDate>Fri, 27 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5638561</guid>        </item>
        <item>
            <title>Kids, Teens Ignore Sun Risks (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5620186&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F30787</link>
            <description>(MedPage Today) -- Most children and adolescents did not regularly use sunscreen despite reporting high rates of sunburn, data from a prospective cohort study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5620186</comments>
            <pubDate>Mon, 23 Jan 2012 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">5620186</guid>        </item>
        <item>
            <title>Melanoma Drug's Link to Second Cancers Explained (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5608947&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FOtherCancers%2F30734</link>
            <description>(MedPage Today) -- The recently approved melanoma drug vemurafenib (Zelboraf) accelerates growth of nonmelanoma skin cancers but does not cause the secondary cancers, an international research team has concluded. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608947</comments>
            <pubDate>Fri, 20 Jan 2012 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">5608947</guid>        </item>
        <item>
            <title>Live Video Consults Linked to Better Derm Outcomes (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5608948&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F30730</link>
            <description>(MedPage Today) -- Live telemedicine consultations led to changes in diagnosis and treatment in a majority of patients with dermatologic conditions, a review of medical records showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608948</comments>
            <pubDate>Wed, 18 Jan 2012 18:30:00 +0100</pubDate>
            <guid isPermaLink="false">5608948</guid>        </item>
        <item>
            <title>Melanoma Mortality Linked to Education Level (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5597809&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F30689</link>
            <description>(MedPage Today) -- The overall death rate from melanoma has been declining among whites in recent years, but only among the most highly educated sector of the population, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597809</comments>
            <pubDate>Tue, 17 Jan 2012 16:43:01 +0100</pubDate>
            <guid isPermaLink="false">5597809</guid>        </item>
        <item>
            <title>Nose Jobs Make People Look Younger</title>
            <link>http://www.medworm.com/index.php?rid=5597810&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FSurgery%2FPlasticSurgery%2F30679</link>
            <description>(MedPage Today) -- People who'd had their noses surgically reshaped had a somewhat more youthful appearance afterward -- whatever their age, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597810</comments>
            <pubDate>Mon, 16 Jan 2012 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">5597810</guid>        </item>
        <item>
            <title>Updated GPA Better Predicts Survival With Brain Mets (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5552405&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FBrainCancer%2F30436</link>
            <description>(MedPage Today) -- The prognosis for cancer patients with brain metastases varies by the type of initial tumor, but the updated Graded Prognostic Assessment tool can help assess survival, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552405</comments>
            <pubDate>Sat, 31 Dec 2011 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">5552405</guid>        </item>
        <item>
            <title>ASCO Picks Top Advances in Cancer Treatment</title>
            <link>http://www.medworm.com/index.php?rid=5544641&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FProstateCancer%2F30384</link>
            <description>(MedPage Today) -- Advances in screening and prevention, treating resistant cancers, and ways to reduce cancer recurrence were all important parts of the progress made against the disease in 2011, according to the American Society of Clinical Oncology. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544641</comments>
            <pubDate>Wed, 28 Dec 2011 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">5544641</guid>        </item>
        <item>
            <title>Skin Cancer More Likely After First Malignancy (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5524871&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F30311</link>
            <description>(MedPage Today) -- Cancer survivors may be at elevated risk of aggressive skin cancer, particularly if they had melanoma before, a population-based study suggested. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524871</comments>
            <pubDate>Tue, 20 Dec 2011 13:30:00 +0100</pubDate>
            <guid isPermaLink="false">5524871</guid>        </item>
        <item>
            <title>Sunless Tanning Cuts Risky UV Exposure (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5524872&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F30304</link>
            <description>(MedPage Today) -- Young women who used sunless tanning products said they spent less time working on real tans in the sun or under ultraviolet lamps, survey results showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524872</comments>
            <pubDate>Mon, 19 Dec 2011 20:27:57 +0100</pubDate>
            <guid isPermaLink="false">5524872</guid>        </item>
        <item>
            <title>Surgery Outcomes Better With Some Fat on the Bones (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5431847&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FSurgery%2FGeneralSurgery%2F29836</link>
            <description>(MedPage Today) -- Surgical patients with a body mass index at the lower end of the normal range were more likely to die within 30 days of the procedure than those in the moderately overweight range, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431847</comments>
            <pubDate>Tue, 22 Nov 2011 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">5431847</guid>        </item>
        <item>
            <title>Acne Treatment Linked to Sore Throats (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5431848&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F29834</link>
            <description>(MedPage Today) -- Oral antibiotics given to clear up acne may bring on sore throats, researchers affirmed, although why that happens remains unclear. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431848</comments>
            <pubDate>Mon, 21 Nov 2011 20:32:16 +0100</pubDate>
            <guid isPermaLink="false">5431848</guid>        </item>
        <item>
            <title>Laser May Offer Way to Treat Melanoma in Situ (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5431849&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F29833</link>
            <description>(MedPage Today) -- Laser ablation may be a useful approach to removing the lesion of primary lentigo maligna, especially if the gold-standard therapy -- surgical excision -- is either unwanted or not possible, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431849</comments>
            <pubDate>Mon, 21 Nov 2011 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">5431849</guid>        </item>
        <item>
            <title>FDA Approves Melanoma Detection Device</title>
            <link>http://www.medworm.com/index.php?rid=5386879&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPublicHealthPolicy%2FFDAGeneral%2F29417</link>
            <description>WASHINGTON (MedPage Today) -- The FDA has approved the computerized melanoma diagnostic tool MelaFind for use on atypical cutaneous pigmented lesions after months of back-and-forth with the device manufacturer. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5386879</comments>
            <pubDate>Wed, 02 Nov 2011 20:41:12 +0100</pubDate>
            <guid isPermaLink="false">5386879</guid>        </item>
        <item>
            <title>Novel Biologic for Psoriasis Bests Methotrexate (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5360475&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F29301</link>
            <description>(MedPage Today) -- Psoriasis responds substantially better to the novel monoclonal antibody briakinumab than to methotrexate, according to randomized trial results, but the drug has some serious side effects. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5360475</comments>
            <pubDate>Mon, 31 Oct 2011 03:13:03 +0100</pubDate>
            <guid isPermaLink="false">5360475</guid>        </item>
        <item>
            <title>Gene Mutation Link to Inflammation Identified (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5335940&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FNeurology%2FGeneralNeurology%2F29140</link>
            <description>(MedPage Today) -- A loss-of-function mutation in a gene known as ADAM17 is likely to be the cause of neonatal inflammatory skin and bowel lesions in two children born to consanguineous parents, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335940</comments>
            <pubDate>Sat, 22 Oct 2011 03:12:59 +0100</pubDate>
            <guid isPermaLink="false">5335940</guid>        </item>
        <item>
            <title>Melanoma Costlier, Cuts Life Shorter than Other Cancers (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5335941&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FOncology%2FSkinCancer%2F29136</link>
            <description>(MedPage Today) -- Melanoma cuts life short by an average of 20 years, and mortality from the disease costs $3.5 billion annually in lost productivity, according to new estimates of the cancer's health and economic burdens. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335941</comments>
            <pubDate>Thu, 20 Oct 2011 16:41:25 +0100</pubDate>
            <guid isPermaLink="false">5335941</guid>        </item>
        <item>
            <title>Hair Salon Serves as Skin Cancer Screening Stop (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5324089&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F29087</link>
            <description>(MedPage Today) -- As hair stylists are snipping, they're also screening for skin cancer. Nearly 40% of hair professionals surveyed said they look for suspicious lesions on their customers' scalps, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324089</comments>
            <pubDate>Tue, 18 Oct 2011 03:13:05 +0100</pubDate>
            <guid isPermaLink="false">5324089</guid>        </item>
        <item>
            <title>AAP: One Course of Spinosad Exterminates Lice, Nits (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5324090&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAPMeeting%2F29065</link>
            <description>BOSTON (MedPage Today) -- Head lice and nits cleared from the hair of 90% of patients following a single application of a soil bacteria-based topical agent, results of a randomized study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5324090</comments>
            <pubDate>Sat, 15 Oct 2011 20:52:08 +0100</pubDate>
            <guid isPermaLink="false">5324090</guid>        </item>
        <item>
            <title>Melanoma Drug Hits Barrier in U.K. Appraisal</title>
            <link>http://www.medworm.com/index.php?rid=5314602&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F29052</link>
            <description>(MedPage Today) -- In draft guidelines, the U.K. board that evaluates new drugs has recommended against using ipilimumab (Yervoy), made by Bristol-Myers Squibb, to treat advanced malignant melanoma in people who have received prior chemotherapy. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314602</comments>
            <pubDate>Sat, 15 Oct 2011 03:13:06 +0100</pubDate>
            <guid isPermaLink="false">5314602</guid>        </item>
        <item>
            <title>Nail Bed Problems Point to Vascular Issues in Glaucoma (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5314603&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FOphthalmology%2FGlaucoma%2F29017</link>
            <description>(MedPage Today) -- Nail bed vascular abnormalities had a significant association with optic disc hemorrhage and other manifestations of glaucoma, data from a Korean clinical series showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5314603</comments>
            <pubDate>Thu, 13 Oct 2011 13:15:27 +0100</pubDate>
            <guid isPermaLink="false">5314603</guid>        </item>
        <item>
            <title>California Bans Tanning Beds for Minors</title>
            <link>http://www.medworm.com/index.php?rid=5304526&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPrimaryCare%2FPreventiveCare%2F28966</link>
            <description>(MedPage Today) -- A new California law that prohibits anyone younger than 18 from using tanning beds drew praise from health organizations when it was signed this weekend. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304526</comments>
            <pubDate>Wed, 12 Oct 2011 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">5304526</guid>        </item>
        <item>
            <title>HPV-Related Anal Cancer Risk High in Lupus (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5273985&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FRheumatology%2FLupus%2F28823</link>
            <description>(MedPage Today) -- Patients with systemic lupus erythematosus are at elevated risk for virus-associated malignancies, data from a Danish registry showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5273985</comments>
            <pubDate>Fri, 30 Sep 2011 20:46:00 +0100</pubDate>
            <guid isPermaLink="false">5273985</guid>        </item>
        <item>
            <title>Melanoma Detector Nears FDA Approval</title>
            <link>http://www.medworm.com/index.php?rid=5260887&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F28757</link>
            <description>(MedPage Today) -- After a long delay, the FDA is poised to approve a computerized melanoma detection system, pending agreement with its manufacturer on labeling, physician training, and postmarketing studies. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5260887</comments>
            <pubDate>Thu, 29 Sep 2011 03:13:01 +0100</pubDate>
            <guid isPermaLink="false">5260887</guid>        </item>
        <item>
            <title>Ultrasonic Bone Removal Aids Nose Sculpting (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5237854&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FSurgery%2FPlasticSurgery%2F28619</link>
            <description>(MedPage Today) -- Outcomes in cosmetic rhinoplasty improved with subtle structural refinements facilitated by an ultrasonic bone aspirator, investigators reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5237854</comments>
            <pubDate>Thu, 22 Sep 2011 03:13:01 +0100</pubDate>
            <guid isPermaLink="false">5237854</guid>        </item>
        <item>
            <title>Laser Therapy Matches Standard Varicose Vein Tx (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5237855&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F28606</link>
            <description>(MedPage Today) -- Newer laser ablation treatment for varicose veins is just as effective as conventional therapy, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5237855</comments>
            <pubDate>Mon, 19 Sep 2011 20:17:25 +0100</pubDate>
            <guid isPermaLink="false">5237855</guid>        </item>
        <item>
            <title>No Eczema Protection from Breastfeeding (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5170405&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FAtopy%2F28239</link>
            <description>(MedPage Today) -- Breastfeeding offered no protection against childhood eczema, according to a survey of more than 50,000 schoolchildren worldwide. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5170405</comments>
            <pubDate>Mon, 29 Aug 2011 13:13:01 +0100</pubDate>
            <guid isPermaLink="false">5170405</guid>        </item>
        <item>
            <title>Vitamin D Linked to Skin Cancer (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5132231&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F28042</link>
            <description>(MedPage Today) -- High levels of vitamin D are associated with an increased risk of nonmelanoma skin cancer, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132231</comments>
            <pubDate>Tue, 16 Aug 2011 20:13:01 +0100</pubDate>
            <guid isPermaLink="false">5132231</guid>        </item>
        <item>
            <title>Beta-Blocker Helps Clear Infant Hemangioma (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5132232&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F28047</link>
            <description>(MedPage Today) -- Treatment of infantile hemangiomas with propranolol was significantly more effective -- and considerably safer -- than standard first-line therapy with oral corticosteroids, a retrospective analysis showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5132232</comments>
            <pubDate>Mon, 15 Aug 2011 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">5132232</guid>        </item>
        <item>
            <title>Lab Notes: Engineered Discs, Smooth Fingertips</title>
            <link>http://www.medworm.com/index.php?rid=5097942&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FLabNotes%2FLabNotes%2F27922</link>
            <description>Spinal discs (MedPage Today) -- the cartilage cushions between vertebrae that distort and tear all too frequently -- were successfully replaced with bioengineered versions grown in situ in rats. Also in this week's Lab Notes, the genetic origin of a bizarre condition marked by lack of fingerprints is nailed down. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5097942</comments>
            <pubDate>Sat, 06 Aug 2011 15:43:00 +0100</pubDate>
            <guid isPermaLink="false">5097942</guid>        </item>
        <item>
            <title>Hemangiomas Erased With Propranolol (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5063896&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F27714</link>
            <description>(MedPage Today) -- The beta-blocker propranolol shrinks potentially disfiguring infantile hemangiomas in young children, a clinical trial affirmed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5063896</comments>
            <pubDate>Tue, 26 Jul 2011 16:43:01 +0100</pubDate>
            <guid isPermaLink="false">5063896</guid>        </item>
        <item>
            <title>Docs Best at Spotting Melanoma Early (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5039811&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FOncology%2FSkinCancer%2F27586</link>
            <description>(MedPage Today) -- Dermatologists detected significantly more melanomas and at an earlier stage than patients did, data from a large single-center cohort study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5039811</comments>
            <pubDate>Wed, 20 Jul 2011 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">5039811</guid>        </item>
        <item>
            <title>Methotrexate Cuts Scleroderma Flares in Kids (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=5030497&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FRheumatology%2FGeneralRheumatology%2F27545</link>
            <description>(MedPage Today) -- Methotrexate is effective in juvenile localized scleroderma when given with a short course of steroids, a randomized study confirmed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5030497</comments>
            <pubDate>Sat, 16 Jul 2011 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">5030497</guid>        </item>
        <item>
            <title>Conversations with... Jeffrey Gershenwald, MD (with video)</title>
            <link>http://www.medworm.com/index.php?rid=5020886&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMultiMedia%2FMultiMedia%2F26941</link>
            <description>(MedPage Today) -- &quot;Conversations with . . .&quot; is a series of exclusive video interviews with leaders of medical research and policy. In this segment, Editor-at-Large George Lundberg, MD, discusses the clinical utility of cancer staging with Jeffrey Gershenwald, MD,of the University of Texas MD Anderson Cancer Center. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5020886</comments>
            <pubDate>Wed, 13 Jul 2011 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">5020886</guid>        </item>
        <item>
            <title>Chronic Itching as Debilitating as Chronic Pain (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4954579&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F27160</link>
            <description>(MedPage Today) -- Chronic pruritus may have a similar effect on quality of life as chronic pain, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4954579</comments>
            <pubDate>Mon, 20 Jun 2011 18:46:51 +0100</pubDate>
            <guid isPermaLink="false">4954579</guid>        </item>
        <item>
            <title>Anti-TNF Drug Helps in Immune Muscle Disorder (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4937038&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FRheumatology%2FGeneralRheumatology%2F27121</link>
            <description>(MedPage Today) -- Treatment with the tumor necrosis factor inhibitor etanercept (Enbrel) was safe and provided steroid-sparing effects in patients with dermatomyositis, a small pilot study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4937038</comments>
            <pubDate>Sat, 18 Jun 2011 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">4937038</guid>        </item>
        <item>
            <title>Top of the Charts at ASCO 2011 (with video)</title>
            <link>http://www.medworm.com/index.php?rid=4923313&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26996</link>
            <description>CHICAGO (MedPage Today) -- As the American Society of Clinical Oncology meeting came to a close, MedPage Today reporters Michael Smith, Crystal Phend, and Charles Bankhead discussed what they saw as the highlights in this exclusive InFocus video report. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4923313</comments>
            <pubDate>Mon, 13 Jun 2011 15:43:01 +0100</pubDate>
            <guid isPermaLink="false">4923313</guid>        </item>
        <item>
            <title>Leukemia Drug May Work for Melanoma Subset (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4913771&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F26952</link>
            <description>(MedPage Today) -- A subset of patients with advanced melanoma harboring KIT alterations may benefit from imatinib mesylate (Gleevec), a small, uncontrolled, phase II study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4913771</comments>
            <pubDate>Fri, 10 Jun 2011 15:43:01 +0100</pubDate>
            <guid isPermaLink="false">4913771</guid>        </item>
        <item>
            <title>ASCO: Women Do Better in Malignant Melanoma</title>
            <link>http://www.medworm.com/index.php?rid=4913772&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26898</link>
            <description>CHICAGO (MedPage Today) -- An analysis of outcomes data from seven European clinical trials showed that women with the disease are less likely to die or to have the cancer progress. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4913772</comments>
            <pubDate>Tue, 07 Jun 2011 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">4913772</guid>        </item>
        <item>
            <title>ASCO: Melanoma Survival Benefit Called 'Astounding' (CME/CE, with video)</title>
            <link>http://www.medworm.com/index.php?rid=4895416&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26853</link>
            <description>CHICAGO (MedPage Today) -- Patients with metastatic melanoma had an &quot;astounding&quot; 63% reduction in the risk of death when treated with an investigational agent that targets a mutation found in about half of the tumors, data from a large international trial showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4895416</comments>
            <pubDate>Sun, 05 Jun 2011 18:13:01 +0100</pubDate>
            <guid isPermaLink="false">4895416</guid>        </item>
        <item>
            <title>ASCO: Melanoma Combo Improves Overall Survival (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4895417&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCOMeeting%2F26852</link>
            <description>(MedPage Today) -- CHICAGO -– Combining a biologic agent with a cytotoxic drug significantly improved overall survival among patients with previously untreated metastatic melanoma, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4895417</comments>
            <pubDate>Sun, 05 Jun 2011 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">4895417</guid>        </item>
        <item>
            <title>Vaccine Boosts Response to Melanoma Tx (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4885848&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F26795</link>
            <description>(MedPage Today) -- A GP100 peptide vaccine significantly enhanced the response to interleukin-2 in patients with advanced melanoma, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4885848</comments>
            <pubDate>Thu, 02 Jun 2011 15:13:01 +0100</pubDate>
            <guid isPermaLink="false">4885848</guid>        </item>
        <item>
            <title>Sunscreen Guidance Half-Baked, Journal Says</title>
            <link>http://www.medworm.com/index.php?rid=4885849&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F26783</link>
            <description>(MedPage Today) -- The British and U.S. governments' official recommendation for minimum SPF levels in sunscreens has come under fire from a leading medical journal as offering inadequate protection. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4885849</comments>
            <pubDate>Wed, 01 Jun 2011 13:30:00 +0100</pubDate>
            <guid isPermaLink="false">4885849</guid>        </item>
        <item>
            <title>Beta-Blocker Effective in Infantile Hemangiomas (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4831632&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F26515</link>
            <description>(MedPage Today) -- The beta-blocker propranolol is an effective treatment for head and neck infantile hemangiomas, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4831632</comments>
            <pubDate>Wed, 18 May 2011 16:43:02 +0100</pubDate>
            <guid isPermaLink="false">4831632</guid>        </item>
        <item>
            <title>SID: Oral Drug Active in Atopic Dermatitis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4798155&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSID%2F26361</link>
            <description>PHOENIX (MedPage Today) -- Half of patients with moderate or severe atopic dermatitis had at least 50% improvement in disease status when treated with an oral phosphodiesterase inhibitor, results of a small clinical study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4798155</comments>
            <pubDate>Sun, 08 May 2011 18:13:01 +0100</pubDate>
            <guid isPermaLink="false">4798155</guid>        </item>
        <item>
            <title>SID: No Skin Cancer Risk Seen With Prednisone (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4790387&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FSID%2F26317</link>
            <description>PHOENIX (MedPage Today) -- Use of systemic corticosteroids did not increase the risk of nonmelanoma skin cancer in a prospective study, contradicting previous evidence from several retrospective studies, investigators reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4790387</comments>
            <pubDate>Fri, 06 May 2011 16:13:00 +0100</pubDate>
            <guid isPermaLink="false">4790387</guid>        </item>
        <item>
            <title>Women Take a Shine to Tanning Despite Risks</title>
            <link>http://www.medworm.com/index.php?rid=4771978&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F26216</link>
            <description>(MedPage Today) -- Despite warnings about melanoma risk, young women and teens still prefer to tan, a new survey says. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4771978</comments>
            <pubDate>Mon, 02 May 2011 16:13:01 +0100</pubDate>
            <guid isPermaLink="false">4771978</guid>        </item>
        <item>
            <title>Study Debunks 'Skin-Thinning' Myth (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4736204&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F26055</link>
            <description>(MedPage Today) -- Fear of topical corticosteroids -- common among parents of children with atopic dermatitis -- is unfounded, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4736204</comments>
            <pubDate>Fri, 22 Apr 2011 16:13:00 +0100</pubDate>
            <guid isPermaLink="false">4736204</guid>        </item>
        <item>
            <title>Acne Meds Not Linked to Resistant Staph (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4705586&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F25873</link>
            <description>(MedPage Today) -- Long-term use of tetracycline agents to treat acne does not appear to lead to high rates of resistant Staphylococcus aureus -- and may actually reduce the risk of colonization with staph bacteria, according to results from a small study of acne patients. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4705586</comments>
            <pubDate>Tue, 12 Apr 2011 17:00:04 +0100</pubDate>
            <guid isPermaLink="false">4705586</guid>        </item>
        <item>
            <title>Abatacept Benefits Joints in Psoriatic Arthritis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4698481&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FRheumatology%2FArthritis%2F25837</link>
            <description>(MedPage Today) -- The T-cell inhibitor abatacept (Orencia) showed benefits for the joint manifestations of psoriatic arthritis, with lesser effects on the skin component of the disease, a multicenter, double-blind trial found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4698481</comments>
            <pubDate>Tue, 12 Apr 2011 15:43:01 +0100</pubDate>
            <guid isPermaLink="false">4698481</guid>        </item>
        <item>
            <title>FDA Approves Melanoma Agent</title>
            <link>http://www.medworm.com/index.php?rid=4665048&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FOncology%2FSkinCancer%2F25665</link>
            <description>(MedPage Today) -- The FDA has cleared peginterferon alfa-2b (Sylatron) to prevent melanoma recurrence following definitive surgical resection in patients with microscopic or gross nodal involvement. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4665048</comments>
            <pubDate>Fri, 01 Apr 2011 17:13:01 +0100</pubDate>
            <guid isPermaLink="false">4665048</guid>        </item>
        <item>
            <title>Money May Buy Higher Melanoma Risk (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4616767&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F25459</link>
            <description>(MedPage Today) -- Girls and young women who live in wealthier neighborhoods and get more sun-soaked recreation appear to have a higher risk of melanoma, a California study suggests. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4616767</comments>
            <pubDate>Tue, 22 Mar 2011 16:43:00 +0100</pubDate>
            <guid isPermaLink="false">4616767</guid>        </item>
        <item>
            <title>Melanoma Affects Life More for Women (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4502946&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F24999</link>
            <description>(MedPage Today) -- Women are more likely than men to feel their quality of life has been affected by melanoma, even up to 10 years after a diagnosis, according to a Dutch survey of cancer patients. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4502946</comments>
            <pubDate>Tue, 22 Feb 2011 15:43:01 +0100</pubDate>
            <guid isPermaLink="false">4502946</guid>        </item>
        <item>
            <title>FDA Okays Dermatitis Gel</title>
            <link>http://www.medworm.com/index.php?rid=4456136&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPublicHealthPolicy%2FFDAGeneral%2F24779</link>
            <description>WASHINGTON (MedPage Today) -- The FDA has approved a new skin care gel for treatment of various dermatoses, burns, and dry and waxy skin. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4456136</comments>
            <pubDate>Thu, 10 Feb 2011 15:13:03 +0100</pubDate>
            <guid isPermaLink="false">4456136</guid>        </item>
        <item>
            <title>Melanoma Drug Extends Survival in Phase II Trial</title>
            <link>http://www.medworm.com/index.php?rid=4373607&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F24419</link>
            <description>(MedPage Today) -- An investigational oral drug targeting a mutated BRAF kinase protein boosted overall survival in patients with metastatic melanoma, its manufacturer said, although the size of the survival benefit wasn't disclosed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4373607</comments>
            <pubDate>Thu, 20 Jan 2011 14:13:03 +0100</pubDate>
            <guid isPermaLink="false">4373607</guid>        </item>
        <item>
            <title>Melanoma Seen Earlier in High-Risk Follow-Up (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4362819&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F24414</link>
            <description>(MedPage Today) -- Specialized follow-up programs for patients at high risk of melanoma appear to lead to earlier detection of the potentially deadly disease, according to a retrospective analysis. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4362819</comments>
            <pubDate>Wed, 19 Jan 2011 14:13:03 +0100</pubDate>
            <guid isPermaLink="false">4362819</guid>        </item>
        <item>
            <title>Comparing Nevi Avoids Unneeded Excisions (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4362820&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F24390</link>
            <description>(MedPage Today) -- Examining an equivocal nevus within the context of a patient's other lesions led to 75% reduction in the decision to remove the nevus -- compared with using a morphologic evaluation, according to a small clinical study. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4362820</comments>
            <pubDate>Mon, 17 Jan 2011 22:04:43 +0100</pubDate>
            <guid isPermaLink="false">4362820</guid>        </item>
        <item>
            <title>Antibody Efficacious in Psoriasis of the Hands and Feet (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4278421&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F24013</link>
            <description>(MedPage Today) -- A biological agent is safe and efficacious in treating severe chronic plaque psoriasis involving the hands and feet, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4278421</comments>
            <pubDate>Wed, 22 Dec 2010 14:43:01 +0100</pubDate>
            <guid isPermaLink="false">4278421</guid>        </item>
        <item>
            <title>Women Lead Men in Indoor Tanning (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4275827&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F23997</link>
            <description>(MedPage Today) -- Women are almost three times as likely as men to use an indoor tanning bed, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4275827</comments>
            <pubDate>Mon, 20 Dec 2010 20:56:25 +0100</pubDate>
            <guid isPermaLink="false">4275827</guid>        </item>
        <item>
            <title>Derm Group Backs Isotretinoin</title>
            <link>http://www.medworm.com/index.php?rid=4215161&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F23639</link>
            <description>(MedPage Today) -- Evidence of increased risk for suicide and inflammatory bowel disease in patients treated with isotretinoin is not strong enough for physicians to stop prescribing the drug to treat severe acne, according to the American Academy of Dermatology. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4215161</comments>
            <pubDate>Wed, 01 Dec 2010 11:13:01 +0100</pubDate>
            <guid isPermaLink="false">4215161</guid>        </item>
        <item>
            <title>Painkiller Shows Promise in Prevention of Skin Cancer (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4208756&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F23643</link>
            <description>(MedPage Today) -- Preliminary research suggests that the painkiller celecoxib (Celebrex) may help prevent nonmelanoma skin cancers, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4208756</comments>
            <pubDate>Tue, 30 Nov 2010 03:13:01 +0100</pubDate>
            <guid isPermaLink="false">4208756</guid>        </item>
        <item>
            <title>FDA Reviewers Skeptical About Melanoma Dx Device</title>
            <link>http://www.medworm.com/index.php?rid=4172807&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F23448</link>
            <description>WASHINGTON (MedPage Today) -- A computer-aided detection device for malignant melanoma met a chilly reception from the FDA's professional staff, who said the device &quot;has not been studied adequately,&quot; according to briefing documents prepared for an advisory committee meeting on Thursday. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4172807</comments>
            <pubDate>Wed, 17 Nov 2010 03:13:01 +0100</pubDate>
            <guid isPermaLink="false">4172807</guid>        </item>
        <item>
            <title>Slather on SPF Before Hitting the Slopes (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4168940&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F23399</link>
            <description>(MedPage Today) -- Skiers and snowboarders should always wear sunscreen -- even when the sun is hiding behind the clouds, researchers say. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4168940</comments>
            <pubDate>Tue, 16 Nov 2010 03:13:03 +0100</pubDate>
            <guid isPermaLink="false">4168940</guid>        </item>
        <item>
            <title>Acne May Increase Suicide Risk (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4160214&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F23332</link>
            <description>(MedPage Today) -- Having acne may increase a patient's risk of suicide, and treatment with isotretinoin (Accutane) may not be to blame, researchers say. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4160214</comments>
            <pubDate>Sat, 13 Nov 2010 02:43:01 +0100</pubDate>
            <guid isPermaLink="false">4160214</guid>        </item>
        <item>
            <title>Risk Not Always Prime Mover for Skin CA Screening (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4089789&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F22863</link>
            <description>(MedPage Today) -- Individuals who seek skin cancer screening often are not those who need it most, a survey conducted in an academic dermatology department found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4089789</comments>
            <pubDate>Sun, 24 Oct 2010 01:13:01 +0100</pubDate>
            <guid isPermaLink="false">4089789</guid>        </item>
        <item>
            <title>Computer Bests Physicians at Melanoma Detection (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4089790&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F22861</link>
            <description>(MedPage Today) -- An automated, computerized imaging and diagnostic system appears to find small, pigmented melanomas better than dermatologists, at least by some measures, according to a company-sponsored trial. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4089790</comments>
            <pubDate>Wed, 20 Oct 2010 14:30:00 +0100</pubDate>
            <guid isPermaLink="false">4089790</guid>        </item>
        <item>
            <title>Photoprotection Linked to Low Vitamin D Levels (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4078461&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F22814</link>
            <description>(MedPage Today) -- Patients with basal cell nevus syndrome, which increases the risk of skin cancer, may have an increased risk of vitamin D deficiency as a consequence of their photoprotection practices, investigators reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4078461</comments>
            <pubDate>Tue, 19 Oct 2010 12:43:01 +0100</pubDate>
            <guid isPermaLink="false">4078461</guid>        </item>
        <item>
            <title>Dogs and Cats Have Opposite Effects on Kids' Eczema (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=4019436&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F22488</link>
            <description>(MedPage Today) -- Good news for dog owners looking to raise a kid, but bad news for cat owners -- Fido may help prevent your child from developing eczema, but Mittens may make it worse, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4019436</comments>
            <pubDate>Fri, 01 Oct 2010 13:43:01 +0100</pubDate>
            <guid isPermaLink="false">4019436</guid>        </item>
        <item>
            <title>Cryotherapy Best for Common Warts (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3962975&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F22124</link>
            <description>(MedPage Today) -- Cryotherapy was superior to topical salicylic acid for the treatment of common warts, a Dutch randomized trial found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3962975</comments>
            <pubDate>Tue, 14 Sep 2010 03:13:01 +0100</pubDate>
            <guid isPermaLink="false">3962975</guid>        </item>
        <item>
            <title>Targeted Therapy Shows Early Promise in Melanoma (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3900768&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F21881</link>
            <description>(MedPage Today) -- A novel drug targeted to a common mutation behind melanoma appears effective in skin tumors that carry the mutation, according to early results. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3900768</comments>
            <pubDate>Thu, 26 Aug 2010 03:13:01 +0100</pubDate>
            <guid isPermaLink="false">3900768</guid>        </item>
        <item>
            <title>Cell Therapy Tops Foot Ulcer Healing (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3878248&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FEndocrinology%2FDiabetes%2F21724</link>
            <description>(MedPage Today) -- Engineered skin significantly improved healing of diabetic foot ulcers compared with other advanced biologic therapies, according to an analysis of a larger wound care database. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3878248</comments>
            <pubDate>Thu, 19 Aug 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3878248</guid>        </item>
        <item>
            <title>Psoriasis Phototherapy Increases Vitamin D, Too (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3873891&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F21716</link>
            <description>(MedPage Today) -- In patients with psoriasis, narrow-band ultraviolet-B light increased serum vitamin D levels while clearing the condition, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3873891</comments>
            <pubDate>Wed, 18 Aug 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3873891</guid>        </item>
        <item>
            <title>Regular Beer Boosts Women's Psoriasis Risk (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3869969&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F21705</link>
            <description>(MedPage Today) -- Women who drink five or more regular beers a week may double their risk of developing psoriasis, a prospective cohort study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3869969</comments>
            <pubDate>Tue, 17 Aug 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3869969</guid>        </item>
        <item>
            <title>Psoriasis Linked to Depression, Anxiety (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3869971&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F21696</link>
            <description>(MedPage Today) -- People with psoriasis have an increased risk of depression, anxiety, and suicidal thoughts, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3869971</comments>
            <pubDate>Mon, 16 Aug 2010 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">3869971</guid>        </item>
        <item>
            <title>Redheads Seem to Have Multiple BCCs (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3869970&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F21695</link>
            <description>(MedPage Today) -- Redheads appear to be at the highest risk for developing multiple basal cell carcinomas, according to a Dutch population-based study. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3869970</comments>
            <pubDate>Mon, 16 Aug 2010 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">3869970</guid>        </item>
        <item>
            <title>Marrow Transplant Risky -- But May Help Rare Skin Disease (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3856168&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F21641</link>
            <description>(MedPage Today) -- Bone marrow transplantation may help fight a rare genetic blistering skin disease -- but could be too risky for any but the severest cases, according to a small study. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3856168</comments>
            <pubDate>Thu, 12 Aug 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3856168</guid>        </item>
        <item>
            <title>Obesity in Young Adults May Predict Later PsA (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3768555&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F21258</link>
            <description>Obesity in early adulthood is an independent risk factor for the development of psoriatic arthritis, a large case series found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3768555</comments>
            <pubDate>Wed, 21 Jul 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3768555</guid>        </item>
        <item>
            <title>ENDO: Growth Hormone Helps in Muscular Dystrophy (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3692511&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FENDO%2F20875</link>
            <description>SAN DIEGO (MedPage Today) -- Growth hormone therapy improved glucocorticoid-induced growth failure and metabolic abnormalities in boys with muscular dystrophy, according to a small case series study presented here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3692511</comments>
            <pubDate>Fri, 25 Jun 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3692511</guid>        </item>
        <item>
            <title>Sweat Gland and Hair Follicle Cancers Increasing (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3681218&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F20795</link>
            <description>There has been a steady increase in cancers of the sweat glands and hair follicles (MedPage Today) -- cutaneous appendageal carcinomas -- since the late 1970s, although the incidence of the tumors remains low, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3681218</comments>
            <pubDate>Tue, 22 Jun 2010 03:13:02 +0100</pubDate>
            <guid isPermaLink="false">3681218</guid>        </item>
        <item>
            <title>ASCO: Targeted Agent Extends Survival in Metastatic Melanoma (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3632945&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCO%2F20490</link>
            <description>CHICAGO (MedPage Today) -- The first-ever overall survival benefit with any treatment in a metastatic melanoma clinical trial has been reported with the immune-stimulating agent ipilimumab. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3632945</comments>
            <pubDate>Sun, 06 Jun 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3632945</guid>        </item>
        <item>
            <title>Indoor Tanning Linked to Melanoma (CME/CE, with video)</title>
            <link>http://www.medworm.com/index.php?rid=3600933&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F20324</link>
            <description>Indoor tanning is associated with a 74% higher risk of melanoma, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3600933</comments>
            <pubDate>Thu, 27 May 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3600933</guid>        </item>
        <item>
            <title>No Fracture Risk with Acne, Psoriasis Medications (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3574899&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F20168</link>
            <description>There is no risk of fracture associated with vitamin A analogues used to treat such skin conditions as acne and psoriasis, Danish researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3574899</comments>
            <pubDate>Wed, 19 May 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3574899</guid>        </item>
        <item>
            <title>Tanning Initiative Found Effective (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3574900&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F20152</link>
            <description>An appearance-based intervention to prevent skin cancer was effective in reducing indoor tanning among college women for reasons other than personal appearance, a secondary analysis from a randomized trial found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3574900</comments>
            <pubDate>Tue, 18 May 2010 13:14:27 +0100</pubDate>
            <guid isPermaLink="false">3574900</guid>        </item>
        <item>
            <title>Immune System Suppression with Steroids for Hemangiomas (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3570987&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPediatrics%2FGeneralPediatrics%2F20139</link>
            <description>Corticosteroid treatment of infantile hemangiomas led to profound but largely reversible immune suppression in young infants, results of a small prospective study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3570987</comments>
            <pubDate>Tue, 18 May 2010 12:43:03 +0100</pubDate>
            <guid isPermaLink="false">3570987</guid>        </item>
        <item>
            <title>'Suntelligence' Score Low, Survey Finds</title>
            <link>http://www.medworm.com/index.php?rid=3524974&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F19864</link>
            <description>Although most people are concerned about skin cancer and think it's important to protect against it, their attitudes and behaviors don't reflect that concern, results of an American Academy of Dermatology survey showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3524974</comments>
            <pubDate>Mon, 03 May 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3524974</guid>        </item>
        <item>
            <title>Vitiligo Shares Genetic Roots with Skin Cancer (CME/CE, with audio)</title>
            <link>http://www.medworm.com/index.php?rid=3491837&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F19676</link>
            <description>An unexpected genetic link between the hair and skin pigmentation disorder vitiligo and malignant melanoma may have implications for treatment of both, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3491837</comments>
            <pubDate>Thu, 22 Apr 2010 12:43:03 +0100</pubDate>
            <guid isPermaLink="false">3491837</guid>        </item>
        <item>
            <title>Online Dermatology Visits as Effective as In-Person Visits (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3491838&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F19654</link>
            <description>Acne patients who received online treatment from dermatologists had similar outcomes to patients who were treated in the doctor's office, a new study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3491838</comments>
            <pubDate>Wed, 21 Apr 2010 13:03:05 +0100</pubDate>
            <guid isPermaLink="false">3491838</guid>        </item>
        <item>
            <title>Indoor Tanning Can Be an Addiction (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3484040&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F19634</link>
            <description>&quot;Jersey Shore&quot; wannabes beware: some people crave the indoor tanning experience so much that it qualifies as an addiction, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3484040</comments>
            <pubDate>Tue, 20 Apr 2010 14:43:02 +0100</pubDate>
            <guid isPermaLink="false">3484040</guid>        </item>
        <item>
            <title>FDA Okays Actinic Keratosis Cream</title>
            <link>http://www.medworm.com/index.php?rid=3409442&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FProductAlert%2FPrescriptions%2F19256</link>
            <description>WASHINGTON (MedPage Today) -- The FDA has approved imiquimod cream 3.75% (Zyclara) for treatment of actinic keratosis. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3409442</comments>
            <pubDate>Sat, 27 Mar 2010 13:43:02 +0100</pubDate>
            <guid isPermaLink="false">3409442</guid>        </item>
        <item>
            <title>Minors Shouldn't Use Tanning Beds, Panel Says</title>
            <link>http://www.medworm.com/index.php?rid=3409443&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FProductAlert%2FDevicesandVaccines%2F19255</link>
            <description>WASHINGTON (MedPage Today) -- A group of dermatology and plastic surgery experts recommended to the FDA that minors be barred from indoor tanning and suggested tighter controls on tanning beds. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3409443</comments>
            <pubDate>Fri, 26 Mar 2010 20:43:35 +0100</pubDate>
            <guid isPermaLink="false">3409443</guid>        </item>
        <item>
            <title>FDA Okays Acne Lotion</title>
            <link>http://www.medworm.com/index.php?rid=3396578&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FProductAlert%2FDevicesandVaccines%2F19184</link>
            <description>WASHINGTON (MedPage Today) -- The FDA has approved a lotion formulation of the acne treatment adapalene (Differin) 0.1% for patients 12 and older. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3396578</comments>
            <pubDate>Wed, 24 Mar 2010 13:43:02 +0100</pubDate>
            <guid isPermaLink="false">3396578</guid>        </item>
        <item>
            <title>Nonmelanoma Skin Cancer Now Epidemic (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3375662&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F19076</link>
            <description>The rate of nonmelanoma skin cancer in the U.S. is reaching epidemic proportions, with more than two million people affected in 2006, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3375662</comments>
            <pubDate>Thu, 18 Mar 2010 13:43:03 +0100</pubDate>
            <guid isPermaLink="false">3375662</guid>        </item>
        <item>
            <title>AAD: One Pill a Day Works Against Onychomycosis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3360541&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18980</link>
            <description>MIAMI BEACH (MedPage Today) -- A single high-dose tablet of an oral antifungal taken once a day cleared onychomycosis with efficacy similar to conventional treatment with two lower doses of the same drug, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360541</comments>
            <pubDate>Sat, 13 Mar 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3360541</guid>        </item>
        <item>
            <title>AAD: Once-Daily Antifungal Clears Athlete's Foot (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3360542&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18978</link>
            <description>MIAMI BEACH (MedPage Today) -- Application of a topical antifungal once a day led to complete or marked clearance of interdigital tinea pedis and negative culture in almost 90% of patients involved in a small clinical study reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360542</comments>
            <pubDate>Fri, 12 Mar 2010 16:07:22 +0100</pubDate>
            <guid isPermaLink="false">3360542</guid>        </item>
        <item>
            <title>AAD: Restarting Anti-TNF Agent Works in Relapsed Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3360543&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18977</link>
            <description>MIAMI BEACH (MedPage Today) -- A majority of patients with relapsed psoriasis regained control of the disease when retreated with the tumor necrosis factor (TNF) inhibitor adalimumab (Humira), results of a small clinical study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360543</comments>
            <pubDate>Fri, 12 Mar 2010 15:51:40 +0100</pubDate>
            <guid isPermaLink="false">3360543</guid>        </item>
        <item>
            <title>AAD: Psoriasis Increases Pregnancy Risks (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3355886&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18962</link>
            <description>MIAMI BEACH (MedPage Today) -- Pregnant women with psoriasis had a significantly increased risk of poor outcomes, including spontaneous abortion, preterm birth, preeclampsia, placenta previa, and ectopic pregnancy, data from a retrospective chart review showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3355886</comments>
            <pubDate>Fri, 12 Mar 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3355886</guid>        </item>
        <item>
            <title>Drug-Resistant Lice Respond Better to Ivermectin (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3351759&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F18920</link>
            <description>The antiparasitic drug ivermectin (Stromectol) is more effective than malathion lotion for treating infections of drug-resistant lice, a new study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351759</comments>
            <pubDate>Thu, 11 Mar 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3351759</guid>        </item>
        <item>
            <title>AAD: Signal Inhibitor Active in Basal Cell Carcinoma (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3351760&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18915</link>
            <description>MIAMI BEACH (MedPage Today) -- More than half of patients with locally advanced or metastatic basal cell carcinoma responded to an investigational signal transduction inhibitor, data from a phase I clinical trial showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351760</comments>
            <pubDate>Wed, 10 Mar 2010 15:03:26 +0100</pubDate>
            <guid isPermaLink="false">3351760</guid>        </item>
        <item>
            <title>AAD: HIFU Shows Promise for Body Sculpting (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3347855&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18902</link>
            <description>MIAMI BEACH (MedPage Today) -- High-intensity focused ultrasound (HIFU) showed potential as a noninvasive way to remove excess subcutaneous fat, according to results of a small, preliminary clinical study. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3347855</comments>
            <pubDate>Wed, 10 Mar 2010 13:13:02 +0100</pubDate>
            <guid isPermaLink="false">3347855</guid>        </item>
        <item>
            <title>ACS Stats Find Gains in War on Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3347856&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FHematology%2F18901</link>
            <description>Cancer is not quite the killer it was 20 years ago. The American Cancer Society found that &quot;age-standardized&quot; cancer deaths among men declined by 21% from 1990, while the rate among women declined by 12% from 1991 to 2006. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3347856</comments>
            <pubDate>Tue, 09 Mar 2010 20:44:09 +0100</pubDate>
            <guid isPermaLink="false">3347856</guid>        </item>
        <item>
            <title>AAD: When First Anti-TNF Fails Try a Second One (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3347857&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18891</link>
            <description>MIAMI BEACH (MedPage Today) -- Half of patients with psoriasis unresponsive to high-dose etanercept (Enbrel) achieved significant improvement with ustekinumab (Stelara), investigators in a randomized clinical trial reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3347857</comments>
            <pubDate>Tue, 09 Mar 2010 14:55:27 +0100</pubDate>
            <guid isPermaLink="false">3347857</guid>        </item>
        <item>
            <title>AAD: Sequenced TNF Blockers Control Psoriasis (CME/CE, with video)</title>
            <link>http://www.medworm.com/index.php?rid=3347858&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18889</link>
            <description>MIAMI BEACH (MedPage Today) -- Two-thirds of psoriasis patients who had inadequate responses to etanercept (Enbrel) achieved total clearance or minimal disease activity with infliximab (Remicade), according to data reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3347858</comments>
            <pubDate>Tue, 09 Mar 2010 14:00:59 +0100</pubDate>
            <guid isPermaLink="false">3347858</guid>        </item>
        <item>
            <title>AAD: Psoriasis Comorbidity Increases over Time (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3343967&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18870</link>
            <description>MIAMI BEACH (MedPage Today) -- Patients with psoriasis have multiple comorbid conditions that tend to worsen over time, data from a review of medical records showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3343967</comments>
            <pubDate>Tue, 09 Mar 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3343967</guid>        </item>
        <item>
            <title>AAD: Low Infection Risk Seen with Methotrexate (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3340401&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18854</link>
            <description>MIAMI BEACH (MedPage Today) -- Methotrexate appears to pose only a small risk of serious infection with long-term use, according to results of a meta-analysis reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3340401</comments>
            <pubDate>Mon, 08 Mar 2010 13:13:03 +0100</pubDate>
            <guid isPermaLink="false">3340401</guid>        </item>
        <item>
            <title>AAD: Topical Agent Clears Actinic Keratoses (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3339195&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FAAD%2F18849</link>
            <description>MIAMI BEACH (MedPage Today) -- More than 70% of patients with actinic keratoses had complete or partial clearance of lesions after two applications of a plant-derived topical agent, data from a randomized trial showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3339195</comments>
            <pubDate>Sun, 07 Mar 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3339195</guid>        </item>
        <item>
            <title>Severe Acne Responds to Combo Therapy (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3336552&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F18837</link>
            <description>Patients with severe acne had significantly greater improvement when topical adapalene/benzoyl peroxide (Epiduo) was added to oral doxycycline, according to results of a randomized clinical trial. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3336552</comments>
            <pubDate>Sat, 06 Mar 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3336552</guid>        </item>
        <item>
            <title>Severe Acne Responds to Combo Therapy (CME/CE, with audio)</title>
            <link>http://www.medworm.com/index.php?rid=3340402&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F18837</link>
            <description>Patients with severe acne had significantly greater improvement when topical adapalene/benzoyl peroxide (Epiduo) was added to oral doxycycline, according to results of a randomized clinical trial. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3340402</comments>
            <pubDate>Fri, 05 Mar 2010 18:05:26 +0100</pubDate>
            <guid isPermaLink="false">3340402</guid>        </item>
        <item>
            <title>Psoriasis Drug Efficacy Decreases as Antibodies Rise (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3281143&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F18518</link>
            <description>Some psoriasis patients who take adalimumab (Humira) for treatment of plaque psoriasis become unresponsive to the drug over time, a new Dutch study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3281143</comments>
            <pubDate>Thu, 18 Feb 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3281143</guid>        </item>
        <item>
            <title>New Laser Surgery Gets Rid of Some Scars (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3273769&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F18478</link>
            <description>Ablative fractional resurfacing is a safe and effective way to remove atrophic scars from surgery or trauma, a new study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3273769</comments>
            <pubDate>Tue, 16 Feb 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3273769</guid>        </item>
        <item>
            <title>Tailor Etanercept to Symptoms in Psoriasis and Psoriatic Arthritis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3241135&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FRheumatology%2FArthritis%2F18309</link>
            <description>The decision to use once-weekly or twice-weekly etanercept in patients with both psoriasis and psoriatic arthritis should be determined by the cutaneous and joint symptoms of the patient, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3241135</comments>
            <pubDate>Fri, 05 Feb 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3241135</guid>        </item>
        <item>
            <title>Scrubbing Away Germs Can Backfire on Backsides (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3202552&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPediatrics%2FGeneralPediatrics%2F18121</link>
            <description>Rashes from toilet seats are once again afflicting American children, and the rare condition is often misdiagnosed, which may delay proper treatment. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3202552</comments>
            <pubDate>Mon, 25 Jan 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3202552</guid>        </item>
        <item>
            <title>Rising Costs -- the Real Heartbreak of Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3186857&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F18028</link>
            <description>Treatment costs for psoriasis have outpaced inflation, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3186857</comments>
            <pubDate>Wed, 20 Jan 2010 13:13:02 +0100</pubDate>
            <guid isPermaLink="false">3186857</guid>        </item>
        <item>
            <title>New Biologic Bests Older One in Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3177184&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F17979</link>
            <description>The dual cytokine inhibitor ustekinumab (Stelara) outperformed etanercept (Enbrel) for treatment of psoriasis, investigators in a multicenter clinical trial reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3177184</comments>
            <pubDate>Sat, 16 Jan 2010 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3177184</guid>        </item>
        <item>
            <title>Skin Cancer Risk High After Heart Transplant (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3125313&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F17699</link>
            <description>Nearly half of heart transplant patients at the Mayo Clinic developed skin cancers during follow-up, particularly squamous cell and basal cell carcinomas, researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3125313</comments>
            <pubDate>Tue, 29 Dec 2009 12:43:02 +0100</pubDate>
            <guid isPermaLink="false">3125313</guid>        </item>
        <item>
            <title>Assisted Delivery More Common for Moms with Low Thyroid Levels (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3112529&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FOBGYN%2FGeneralOBGYN%2F17663</link>
            <description>Otherwise healthy moms with low thyroid levels during the final weeks of pregnancy face an increased risk of abnormal fetal presentation and of requiring assisted delivery, Dutch researchers reported. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112529</comments>
            <pubDate>Wed, 23 Dec 2009 04:01:00 +0100</pubDate>
            <guid isPermaLink="false">3112529</guid>        </item>
        <item>
            <title>Skin Cancer History May Lead to Wrinkles (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3109176&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F17639</link>
            <description>Wrinkles may be the result of several environmental factors (MedPage Today) -- smoking, being heavier, and not wearing sunscreen, according to results of a study of twins. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3109176</comments>
            <pubDate>Mon, 21 Dec 2009 21:03:38 +0100</pubDate>
            <guid isPermaLink="false">3109176</guid>        </item>
        <item>
            <title>'Wear Ur SPF' Text Reminders Increase Sunscreen Use (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=3001345&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F17055</link>
            <description>Using text messages to remind patients to wear their sunscreen may increase their compliance, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3001345</comments>
            <pubDate>Tue, 17 Nov 2009 14:28:27 +0100</pubDate>
            <guid isPermaLink="false">3001345</guid>        </item>
        <item>
            <title>ASTRO: Radiation Blocks Recurrence in High-Risk Melanoma (CME/CE, with video)</title>
            <link>http://www.medworm.com/index.php?rid=2956197&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASTRO%2F16755</link>
            <description>CHICAGO (MedPage Today) -- Radiation therapy after lymphadenectomy significantly reduced the risk of recurrence in patients with high-risk melanoma, according to a first-of-its-kind randomized clinical trial. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2956197</comments>
            <pubDate>Mon, 02 Nov 2009 21:04:58 +0100</pubDate>
            <guid isPermaLink="false">2956197</guid>        </item>
        <item>
            <title>ASTRO: Radiation Blocks Recurrence in High-Risk Melanoma (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2951910&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASTRO%2F16755</link>
            <description>CHICAGO (MedPage Today) -- Radiation therapy after lymphadenectomy significantly reduced the risk of recurrence in patients with high-risk melanoma, according to a first-of-its-kind randomized clinical trial. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2951910</comments>
            <pubDate>Mon, 02 Nov 2009 21:04:58 +0100</pubDate>
            <guid isPermaLink="false">2951910</guid>        </item>
        <item>
            <title>Residents Lack Skill in Skin Cancer Exams (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2910038&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F16504</link>
            <description>Opportunities to learn how to perform skin cancer examinations during medical training are inadequate, with three-quarters of residents reporting never having been taught this skill, a survey found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2910038</comments>
            <pubDate>Tue, 20 Oct 2009 13:28:12 +0100</pubDate>
            <guid isPermaLink="false">2910038</guid>        </item>
        <item>
            <title>ACR: Rheumatoid Arthritis Biologics Increase Risk of Common Skin Cancer (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2903544&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FACR%2F16486</link>
            <description>PHILADELPHIA (MedPage Today) -- Rheumatoid arthritis patients being treated with potent tumor necrosis factor inhibitors run an increased risk of developing skin cancer, researchers said here at the American College of Rheumatology's annual meeting. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2903544</comments>
            <pubDate>Mon, 19 Oct 2009 03:50:24 +0100</pubDate>
            <guid isPermaLink="false">2903544</guid>        </item>
        <item>
            <title>EADV: Psoriasis Comorbidities May Cut Longevity (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2892145&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16436</link>
            <description>BERLIN (MedPage Today) -- Psoriasis patients have a substantial comorbidity burden that can reduce life expectancy by 10 years or more, according to data presented here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2892145</comments>
            <pubDate>Wed, 14 Oct 2009 17:20:27 +0100</pubDate>
            <guid isPermaLink="false">2892145</guid>        </item>
        <item>
            <title>EADV: Benefit of Methrotrexate in Psoriasis Will Show Up Early (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2892146&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16432</link>
            <description>BERLIN (MedPage Today) -- A suboptimal response to methotrexate at 12 weeks identified psoriasis patients who were unlikely to benefit from continued therapy at higher doses, a retrospective analysis of clinical-trial data showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2892146</comments>
            <pubDate>Wed, 14 Oct 2009 15:28:29 +0100</pubDate>
            <guid isPermaLink="false">2892146</guid>        </item>
        <item>
            <title>EADV: Agent Clears Lesions, Lessens Psoriatic Arthritis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2892147&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16431</link>
            <description>BERLIN (MedPage Today) -- In patients with psoriasis and concomitant psoriatic arthritis, treatment with etanercept (Enbrel) improved skin lesions, enthesitis, and dactylitis in a majority of patients, data from a randomized clinical trial showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2892147</comments>
            <pubDate>Wed, 14 Oct 2009 15:01:41 +0100</pubDate>
            <guid isPermaLink="false">2892147</guid>        </item>
        <item>
            <title>EADV: Anti-TNF Exposure Does Not Rule out TNF Inhibitor for Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2887974&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16429</link>
            <description>BERLIN (MedPage Today) -- Prior exposure to anti-tumor necrosis factor (TNF) therapy does not rule out potential benefits from additional anti-TNF therapy for patients with psoriasis, according to data presented here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2887974</comments>
            <pubDate>Tue, 13 Oct 2009 22:32:19 +0100</pubDate>
            <guid isPermaLink="false">2887974</guid>        </item>
        <item>
            <title>EADV: Cytokine Inhibitor Has High  Psoriasis Response (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2884049&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16403</link>
            <description>BERLIN (MedPage Today) -- More than 80% of patients with moderate to severe psoriasis had major responses to an investigational interleukin inhibitor, investigators reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2884049</comments>
            <pubDate>Mon, 12 Oct 2009 21:22:16 +0100</pubDate>
            <guid isPermaLink="false">2884049</guid>        </item>
        <item>
            <title>EADV: Interleukin Inhibitor Works Across Psoriasis Subgroups (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2884050&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16401</link>
            <description>BERLIN (MedPage Today) -- A newly approved cytokine inhibitor demonstrated consistent activity across a range of psoriasis patient subgroups and showed no loss of efficacy in heavier patients with appropriate dosing, according to data reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2884050</comments>
            <pubDate>Mon, 12 Oct 2009 20:12:35 +0100</pubDate>
            <guid isPermaLink="false">2884050</guid>        </item>
        <item>
            <title>EADV: Systemic Psoriasis Therapy Often Delayed (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2884051&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16385</link>
            <description>BERLIN (MedPage Today) -- Patients with psoriasis resistant to topical therapy frequently wait a year or longer to receive systemic therapy, investigators reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2884051</comments>
            <pubDate>Mon, 12 Oct 2009 14:10:38 +0100</pubDate>
            <guid isPermaLink="false">2884051</guid>        </item>
        <item>
            <title>EADV: High Rate of Metabolic Syndrome in Psoriasis Patients (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2877536&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16371</link>
            <description>BERLIN (MedPage Today) -- More than half of patients with psoriasis met diagnostic criteria for metabolic syndrome and had a high prevalence of associated risk factors, according to data from a small cohort study. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2877536</comments>
            <pubDate>Fri, 09 Oct 2009 19:50:12 +0100</pubDate>
            <guid isPermaLink="false">2877536</guid>        </item>
        <item>
            <title>EADV: TNF Inhibitor Active in Palmoplantar Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2877537&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16367</link>
            <description>BERLIN (MedPage Today) -- Patients with palmoplantar psoriasis had at least 50% improvement after 14 weeks when treated with a tumor necrosis factor (TNF) inhibitor, according to results of a small clinical trial reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2877537</comments>
            <pubDate>Fri, 09 Oct 2009 18:20:14 +0100</pubDate>
            <guid isPermaLink="false">2877537</guid>        </item>
        <item>
            <title>EADV: Scalp, Nail Psoriasis Improve with TNF Inhibitor (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2877538&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FEADV%2F16355</link>
            <description>BERLIN (MedPage Today) -- Treatment with a tumor necrosis factor (TNF) inhibitor significantly improved scalp and nail psoriasis as well as skin lesions, according to a retrospective analysis of a randomized clinical trial. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2877538</comments>
            <pubDate>Fri, 09 Oct 2009 11:56:13 +0100</pubDate>
            <guid isPermaLink="false">2877538</guid>        </item>
        <item>
            <title>Heparin Lesions More Common than Expected (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2840054&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F16181</link>
            <description>Subcutaneous heparin will induce skin lesions in about one in 13 patients, usually as a result of an allergic reaction, German researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2840054</comments>
            <pubDate>Tue, 29 Sep 2009 13:03:19 +0100</pubDate>
            <guid isPermaLink="false">2840054</guid>        </item>
        <item>
            <title>ECCO-ESMO: No Melanoma Survival Benefit with Targeted Agent (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2837157&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FECCO-ESMO%2F16148</link>
            <description>Bevacizumab (Avastin) failed to improve survival in advanced melanoma when added to carboplatin and paclitaxel, results of a randomized, multicenter clinical trial showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2837157</comments>
            <pubDate>Fri, 25 Sep 2009 18:42:19 +0100</pubDate>
            <guid isPermaLink="false">2837157</guid>        </item>
        <item>
            <title>FDA Approves Biologic Drug for Psoriasis</title>
            <link>http://www.medworm.com/index.php?rid=2833168&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FProductAlert%2FPrescriptions%2F16147</link>
            <description>After nearly two years of deliberations, the FDA has finally approved ustekinumab (Stelara) for moderate to severe plaque psoriasis. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833168</comments>
            <pubDate>Fri, 25 Sep 2009 18:22:30 +0100</pubDate>
            <guid isPermaLink="false">2833168</guid>        </item>
        <item>
            <title>Lax Tanning Policies for Kids May Increase Melanoma Risk (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2816033&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F16067</link>
            <description>A majority of tanning facilities would allow a teenager to tan every day for a week straight, against FDA recommendations, researchers say. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2816033</comments>
            <pubDate>Mon, 21 Sep 2009 20:12:37 +0100</pubDate>
            <guid isPermaLink="false">2816033</guid>        </item>
        <item>
            <title>FDA Panel Gives Nod to Two Cancer Drugs</title>
            <link>http://www.medworm.com/index.php?rid=2763531&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FLymphoma%2F15828</link>
            <description>WASHINGTON (MedPage Today) -- An FDA advisory panel on Wednesday recommended the agency approve two investigational drugs to treat two uncommon types of non-Hodgkin's lymphoma. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2763531</comments>
            <pubDate>Thu, 03 Sep 2009 17:23:00 +0100</pubDate>
            <guid isPermaLink="false">2763531</guid>        </item>
        <item>
            <title>Drug Shows Activity in Advanced Basal-Cell Cancer (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2759597&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FBrainCancer%2F15811</link>
            <description>More than half of patients with advanced or metastatic basal-cell cancer had major responses when treated with a drug that targets the hedgehog pathway of growth regulation. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2759597</comments>
            <pubDate>Wed, 02 Sep 2009 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">2759597</guid>        </item>
        <item>
            <title>Psoriasis Patients' Brains Filter Disgusted Looks (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2735666&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FPsoriasis%2F15708</link>
            <description>The brains of patients with psoriasis are less responsive to expressions of disgust on other people's faces, a neurological device that may help them cope with the social stigma of the disease, a new study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2735666</comments>
            <pubDate>Thu, 27 Aug 2009 11:00:00 +0100</pubDate>
            <guid isPermaLink="false">2735666</guid>        </item>
        <item>
            <title>Full-body skin exams detect early skin cancer (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2706278&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FSkinCancer%2F15566</link>
            <description>Dermatologists conducting full-body skin exams are better at detecting skin cancers than are patients themselves, especially in the case of early-stage melanomas that have not invaded below the surface of the skin, a new study found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2706278</comments>
            <pubDate>Mon, 17 Aug 2009 20:59:15 +0100</pubDate>
            <guid isPermaLink="false">2706278</guid>        </item>
        <item>
            <title>Antioxidants Pose No Melanoma Risk (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2706279&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F15559</link>
            <description>Antioxidant supplementation did not increase the risk of melanoma in men or women, analysis of data from a population study of almost 70,000 participants showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2706279</comments>
            <pubDate>Mon, 17 Aug 2009 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">2706279</guid>        </item>
        <item>
            <title>MRSA Is Culprit in Higher Hospitalization Rate</title>
            <link>http://www.medworm.com/index.php?rid=2700888&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FInfectiousDisease%2FGeneralInfectiousDisease%2F15539</link>
            <description>Methicillin-resistant Staphylococcus aureus (MRSA) appears to be driving an increase in the number of people hospitalized with skin and soft tissue infections, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2700888</comments>
            <pubDate>Fri, 14 Aug 2009 18:07:14 +0100</pubDate>
            <guid isPermaLink="false">2700888</guid>        </item>
        <item>
            <title>Diarrhea with Novel Drug Not Prevented by Corticosteroid (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2697300&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FHematologyOncology%2FSkinCancer%2F15515</link>
            <description>Prophylactic corticosteroid treatment may not prevent moderate to severe diarrhea reactions with the novel monoclonal antibody ipilimumab for advanced melanoma, researchers found. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697300</comments>
            <pubDate>Thu, 13 Aug 2009 16:22:32 +0100</pubDate>
            <guid isPermaLink="false">2697300</guid>        </item>
        <item>
            <title>Beta-blocker Quickly Combats Hemangiomas (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2686050&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FPediatrics%2FGeneralPediatrics%2F15447</link>
            <description>The beta-blocker propranolol appears to be an effective and well-tolerated treatment for infantile hemangiomas, according to a new case series in Pediatrics. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2686050</comments>
            <pubDate>Mon, 10 Aug 2009 12:04:17 +0100</pubDate>
            <guid isPermaLink="false">2686050</guid>        </item>
        <item>
            <title>FDA Warns of Pediatric Cancer Risk with TNF Blockers</title>
            <link>http://www.medworm.com/index.php?rid=2669011&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FProductAlert%2FPrescriptions%2F15384</link>
            <description>WASHINGTON (MedPage Today) -- The FDA called for stronger warnings in prescribing information for tumor necrosis factor (TNF) blockers to highlight a greater risk of cancer in children and adolescents. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2669011</comments>
            <pubDate>Tue, 04 Aug 2009 22:46:43 +0100</pubDate>
            <guid isPermaLink="false">2669011</guid>        </item>
        <item>
            <title>Chemo Drug Repairs Sun-Damaged Skin (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2479368&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FDermatology%2FGeneralDermatology%2F14705</link>
            <description>TORONTO (MedPage Today) -- Topical application of the chemotherapy drug fluorouracil, or 5FU, can significantly restore sun-damaged skin, researchers said. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2479368</comments>
            <pubDate>Mon, 15 Jun 2009 20:00:00 +0100</pubDate>
            <guid isPermaLink="false">2479368</guid>        </item>
        <item>
            <title>ASCO: Vaccines Create Buzz but HER-2 in Stomach Cancer May Change Practice</title>
            <link>http://www.medworm.com/index.php?rid=2449081&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FASCO%2F14461</link>
            <description>ORLANDO (MedPage Today) -- A pair of investigational therapeutic cancer vaccines -- one for lymphoma and the other for melanoma -- highlight this MedPage Today InFocus discussion. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2449081</comments>
            <pubDate>Tue, 02 Jun 2009 14:57:54 +0100</pubDate>
            <guid isPermaLink="false">2449081</guid>        </item>
        <item>
            <title>ICD: Antibodies to Infliximab at Play in Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2449082&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FICD%2F14473</link>
            <description>PRAGUE (MedPage Today) -- A third of psoriasis patients treated with infliximab (Remicade) developed antibodies to the agent, which correlated with loss of activity and worsening disease severity, a small clinical study showed. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2449082</comments>
            <pubDate>Mon, 01 Jun 2009 18:50:23 +0100</pubDate>
            <guid isPermaLink="false">2449082</guid>        </item>
        <item>
            <title>ICD: Herpes Virus Linked to Psoriasis (CME/CE)</title>
            <link>http://www.medworm.com/index.php?rid=2449083&amp;cid=s_31743_12_f&amp;fid=31743&amp;url=http%3A%2F%2Fwww.medpagetoday.com%2FMeetingCoverage%2FICD%2F14470</link>
            <description>PRAGUE (MedPage Today) -- More than half of a group of patients with psoriasis tested positive for human herpes virus 8 (HHV-8), suggesting infection might play a role in the etiology of the disease, according to data reported here. (Source: MedPage Today Dermatology)</description>
            <author>MedPage Today Dermatology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2449083</comments>
            <pubDate>Mon, 01 Jun 2009 17:06:26 +0100</pubDate>
            <guid isPermaLink="false">2449083</guid>        </item>
    </channel>
</rss>

